We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock
search icon
We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock

Menu

Nitroso

Nitrosamines are a group of chemical compounds that contain the nitroso functional group (NO) attached to an amine group (-NH). They can form in various ways, including through industrial processes, combustion, and certain chemical reactions, particularly involving nitrites and secondary amines. Nitrosamines are of concern because Many nitrosamines (N-Nitrosamines) are potent genotoxins; some have been classified as possible human carcinogens, although the degree of risk can vary depending on factors such as the amount of exposure and individual susceptibility. Synchemia Research Chemical is dedicated to thoroughly investigating the formation of nitroso impurities in APIs, including those related to the manufacturing processes. This approach indicates a proactive stance toward quality control and regulatory compliance. By exploring all potential sources of nitroso impurities, including those arising from the production processes themselves, Synchemia Research Chemical demonstrates a commitment to ensuring the purity, safety, and efficacy of their pharmaceutical products. Nitrosoamines, including N-Des-methyl Nitroso impurities, are important in pharmaceutical research and development due to their potential impact on drug safety and efficacy. Understanding and controlling the presence of these impurities is crucial for ensuring the quality and safety of pharmaceutical products. Can N-Nitrosamines exist in two different stable forms? N-nitrosamines substituted with two different alkyl groups can exist in two different stable forms distinguishable by several analytical methods. The two rotamers may differ in their overall dipole moment and therefore may posses different chemical and physical properties. Why do I see two peaks when analyzing N-Nitrosamines by HPLC or GC? HPLC and GC)analysis of N-nitrosamines may show two rotamers of the N-nitrosamine as two separate peaks. Whether two peaks are observed depends on the structure of the N-nitrosamine (i.e., symmetric vs. asymmetric) as well as the separation power of the analytical method.
We are the Synchemia Research Chemical specializes in manufacturing and exporting various nitrosoamine compounds, particularly focusing on N-Des-methyl Nitroso impurities of various APIs and nitroso compounds of direct APIs that contain secondary amines. By specializing in the synthesis and export of these compounds, Synchemia Research likely plays a significant role in supporting the pharmaceutical industry's efforts to meet regulatory requirements and ensure the highest standards of quality and safety in drug manufacturing.
download image Download catalogue

Pharmaceutical Reference Standards

Lazertinib Nitroso Impurity 1
Lazertinib Nitroso Impurity 1
CAT No SRC-N0143715
CAS No NA
Mol.F. C15H15ClN6O5
Mol.Wt. 394.8 g/mole
INV STATUS CUSTOM SYNTHESIS
Lazertinib Nitroso Impurity 2
Lazertinib Nitroso Impurity 2
CAT No SRC-N0143716
CAS No NA
Mol.F. C25H22N8O6
Mol.Wt. 530.5 g/mole
INV STATUS CUSTOM SYNTHESIS
Lazertinib Nitroso Impurity 3
Lazertinib Nitroso Impurity 3
CAT No SRC-N0143717
CAS No NA
Mol.F. C27H29N9O5
Mol.Wt. 559.6 g/mole
INV STATUS CUSTOM SYNTHESIS
Lazertinib Nitroso Impurity 4
Lazertinib Nitroso Impurity 4
CAT No SRC-N0143718
CAS No NA
Mol.F. C27H31N9O3
Mol.Wt. 529.6 g/mole
INV STATUS CUSTOM SYNTHESIS
Lazertinib Nitroso Impurity 5
Lazertinib Nitroso Impurity 5
CAT No SRC-N0143719
CAS No NA
Mol.F. C26H27N9O5
Mol.Wt. 545.6g/mole
INV STATUS CUSTOM SYNTHESIS
Lazertinib Nitroso Impurity 6
Lazertinib Nitroso Impurity 6
CAT No SRC-N0143720
CAS No NA
Mol.F. C26H29N9O3
Mol.Wt. 515.6 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Lazertinib
N-Nitroso Lazertinib
CAT No SRC-N0143721
CAS No NA
Mol.F. C30H33N9O4
Mol.Wt. 583.7 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso N-Desmethyl Lazertinib
N-Nitroso N-Desmethyl Lazertinib
CAT No SRC-N0143722
CAS No NA
Mol.F. C29H31N9O4
Mol.Wt. 569.6 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Phenoxymethylpenicillin EP Impurity E
N-Nitroso Phenoxymethylpenicillin EP Impurity E
CAT No SRC-N0143723
CAS No NA
Mol.F. C16H19N3O7S
Mol.Wt. 397.4 g/mole
INV STATUS CUSTOM SYNTHESIS
Phenoxymethylpenicillin N- nitroso EP Impurity F
Phenoxymethylpenicillin N- nitroso EP Impurity F
CAT No SRC-N0143724
CAS No NA
Mol.F. C15H19N3O5S
Mol.Wt. 353.4 g/mole
INV STATUS CUSTOM SYNTHESIS
Benzathine Benzylpenicillin EP Impurity C Nitroso Impurity 1
Benzathine Benzylpenicillin EP Impurity C Nitroso Impurity 1
CAT No SRC-N0143725
CAS No NA
Mol.F. C32H37N5O5S
Mol.Wt. 603.7 g/mole
INV STATUS CUSTOM SYNTHESIS
Benzathine Benzylpenicillin EP Impurity K Nitroso Impurity (Mixture of isomer)
Benzathine Benzylpenicillin EP Impurity K Nitroso Impurity (Mixture of isomer)
CAT No SRC-N0143726
CAS No NA
Mol.F. C48H55N7O9S2
Mol.Wt. 938.1 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Benzylpenicillin EP Impurity E
N-Nitroso Benzylpenicillin EP Impurity E
CAT No SRC-N0143727
CAS No NA
Mol.F. C16H19N3O6S
Mol.Wt. 381.4g/mole
INV STATUS CUSTOM SYNTHESIS
15N2 Dinitroso Benzathine
15N2 Dinitroso Benzathine
CAT No SRC-N0143728
CAS No NA
Mol.F. C16H18N215N2O2
Mol.Wt. 300.3 g/mole
INV STATUS CUSTOM SYNTHESIS
Benzathine Benzylpenicillin EP Impurity C Nitroso Impurity 2
Benzathine Benzylpenicillin EP Impurity C Nitroso Impurity 2
CAT No SRC-N0143729
CAS No NA
Mol.F. C32H37N5O5S
Mol.Wt. 603.7 g/mole
INV STATUS CUSTOM SYNTHESIS
15N Nitroso Benzathine
15N Nitroso Benzathine
CAT No SRC-N0143730
CAS No NA
Mol.F. C16H19N215NO
Mol.Wt. 270.3 g/mole
INV STATUS CUSTOM SYNTHESIS

Let’s advance your research together.

Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.